Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer

Journal of Urology

Volumn 175, Issue 3, 2006, Pages 952-957

  Siddiqui, Sameer A ^a   Sengupta, Shomik ^a   Slezak, Jeffrey M ^a   Bergstralh, Eric J ^a   Leibovich, Bradley C ^a   Myers, Robert P ^a   Zincke, Horst ^a   Blute, Michael L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Age groups; Mortality; Prostate; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; RADICAL RETROPUBIC PROSTATECTOMY; SURVIVAL RATE; TREATMENT OUTCOME;

AGE FACTORS; AGED; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 32044460619     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00339-3     Document Type: Article

References (19)

1. D.P. Sandhu, K.W. Munson, A. Benghiat, I.P. Hopper Natural history and prognosis of prostate carcinoma in adolescents and men under 35 years of age Br J Urol 69: 1992 525
2. D.E. Johnson, J.P. Lanieri Jr., A.G. Ayala Prostatic adenocarcinoma occurring in men under 50 years of age J Surg Oncol 4 1972 207
3. L.A. Kerr, H. Zincke Radical retropubic prostatectomy for prostate cancer in the elderly and the young complications and prognosis Eur Urol 25 1994 305
4. H.B. Carter, J.I. Epstein, A.W. Partin Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease Urology 53 1999 126
5. M. Aleman, P.I. Karakiewicz, P. Kupelian, M.W. Kattan, M. Graefen, I. Cagiannos Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL implications for screening Urology 62 2003 70
6. M.A. Khan, M. Han, A.W. Partin, J.I. Epstein, P.C. Walsh Long-term cancer control of radical prostatectomy in men younger than 50 years of age update 2003 Urology 62 2003 86
7. C.V. Smith, J.J. Bauer, R.R. Connelly, T. Seay, C. Kane, J. Foley Prostate cancer in men age 50 years or younger a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database J Urol 164 2000 1964
8. F.A. Khan, A.V. Kaisary, G.B. Boustead, D.A. Gillatt, M.H. Winkler PSA recurrence following radical prostatectomy is comparable for all age groups in the UK Prostate Cancer Prostatic Dis 8 2005 158
9. J.J. Bauer, R.R. Connelly, I.A. Seterhenn, J. Deausen, S. Srivastava, D.G. McLeod Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer J Urol 159 1998 929
10. S.D. Sweat, E.J. Bergstralh, J. Slezak, M.L. Blute, H. Zincke Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age J Urol 168 2002 525
11. M.J. So, J.C. Cheville, J.A. Katzmann, D.L. Riehle, C.M. Lohse, V.S. Pankratz Factors that influence the measurement of prostate cancer DNA ploidy and proliferation in paraffin embedded tissue evaluated by flow cytometry Mod Pathol 14 2001 906
12. C.L. Amling, E.J. Bergstralh, M.L. Blute, J.M. Slezak, H. Zincke Defining prostate specific antigen progression after radical prostatectomy what is the most appropriate cut point? J Urol 165: 2001 1146
13. F.E. Harrell Jr., R.M. Califf, D.B. Pryor, K.L. Lee, R.A. Rosati Evaluating the yield of medical tests JAMA 247 1982 2543
14. M.L. Blute, E.J. Bergstralh, A. Iocca, B. Scherer, H. Zincke Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy J Urol 165 2001 119
15. T.A. Gooley, W. Leisenring, J. Crowley, B.E. Storer Estimation of failure probabilities in the presence of competing risks new representations of old estimators Stat Med 18 1999 695
16. C. Obek, S. Lai, S. Sadek, F. Civantos, M.S. Soloway Age as a prognostic factor for disease recurrence after radical prostatectomy Urology 54 1999 533
17. S.G. Roberts, M.L. Blute, E.J. Bergstralh, J.M. Slezak, H. Zincke PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer Mayo Clin Proc 76 2001 576
18. H. Zincke, E.J. Bergstralh, M.L. Blute, R.P. Myers, D.M. Barrett, M.M. Lieber Radical prostatectomy for clinically localized prostate cancer long-term results of 1,143 patients from a single institution J Clin Oncol 12 1994 2254
19. M.W. Kattan, J.A. Eastham, A.M. Stapleton, T.M. Wheeler, P.T. Scardino A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90: 1998 766